Form 4: DocGo CEO Bienstock Reports RSU Tax Withholding
Insider Transaction Report
DocGo Inc.'s CEO, Lee Bienstock, reported a transaction involving the withholding of 18,811 restricted stock units to cover tax liabilities.
Summary
- Lee Bienstock, Chief Executive Officer and Director of DocGo Inc., reported a transaction on March 30, 2026.
- The transaction involved the disposition of 18,811 shares of DocGo Common Stock at a price of $0.57 per share.
- This disposition was a tax withholding of restricted stock units (RSUs) to satisfy the reporting person's tax liability.
- The RSUs were originally granted on March 28, 2022, pursuant to the Issuer's 2021 Stock Incentive Plan.
- Following this transaction, Lee Bienstock beneficially owns 2,817,470 shares of Common Stock directly.
- This beneficial ownership includes various tranches of RSUs with future vesting dates ranging from May 12, 2026, to December 12, 2028.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a standard tax-related disposition of vested equity compensation rather than a discretionary sale or purchase.
Positives
- The transaction indicates the vesting of previously granted restricted stock units, which represents earned compensation for the executive.
Negatives
- The disposition of shares, even for tax purposes, reduces the direct equity stake of the CEO in the company.
Future Outlook
The filing details future vesting schedules for various tranches of restricted stock units held by the CEO, with vesting dates extending through December 2028, indicating a long-term incentive structure.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as tax withholdings of restricted stock units, are common occurrences across all industries as part of executive compensation plans. This particular filing does not provide broader industry insights but reflects standard practice for equity-based compensation.
Comparison to Industry Standards
- Tax withholdings of vested equity awards are a standard mechanism for executives to cover tax obligations upon the vesting of restricted stock units. This practice is consistent with compensation structures observed in comparable publicly traded companies, such as Teladoc Health (TDOC) or Amwell (AMWL), which also utilize RSU grants as a significant component of executive compensation, often leading to similar tax-related dispositions.
Related Party Transactions
- The transaction involves the withholding of shares by Lee Bienstock, the Chief Executive Officer and a Director of DocGo Inc., to satisfy tax liabilities related to vested restricted stock units granted by the company. This is a standard related-party transaction within the scope of executive compensation.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine tax-related transaction by an insider.
- Positive for the executive as it represents the realization of vested equity compensation.
- No direct impact on customers, suppliers, or creditors.
Next Steps
- Vesting of 402,745 RSUs in three equal annual installments on December 12, 2026, December 12, 2027, and December 12, 2028.
- Vesting of 60,975 RSUs in two equal annual installments on May 12, 2026, and May 12, 2027.
- Vesting of 570,402 RSUs in two equal annual installments on December 12, 2026, and December 12, 2027.
- Vesting of 1,113,495 RSUs in four equal annual installments on the first four anniversaries of December 12, 2025.
Key Dates
| Date | Description |
|---|---|
| March 28, 2022 | Original grant date of the restricted stock units (RSUs) to the Reporting Person under the 2021 Stock Incentive Plan. |
| December 12, 2025 | First anniversary for a tranche of 1,113,495 RSUs to begin vesting in four equal annual installments. |
| May 12, 2026 | First annual installment vesting date for a tranche of 60,975 RSUs. |
| December 12, 2026 | First annual installment vesting date for tranches of 402,745 RSUs and 570,402 RSUs. |
| March 30, 2026 | Date of the reported transaction (tax withholding of RSUs). |
| March 31, 2026 | Signature date of the Form 4 filing. |
| May 12, 2027 | Second annual installment vesting date for a tranche of 60,975 RSUs. |
| December 12, 2027 | Second annual installment vesting date for tranches of 402,745 RSUs and 570,402 RSUs. |
| December 12, 2028 | Third annual installment vesting date for a tranche of 402,745 RSUs. |
Recommendation
holdThis Form 4 filing details a routine tax withholding transaction by the CEO, which is a non-discretionary event related to vested equity compensation. It does not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell the stock.
Keywords
DocGo, DCGO, Lee Bienstock, Form 4, SEC Filing, Restricted Stock Units, RSU, Tax Withholding, Insider Transaction, Executive Compensation, Stock Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.